Browsing: weightloss

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s (NYSE:) weight-loss treatment Zepbound for…

Investing.com — Eli Lilly & Co. (NYSE:) plans to begin selling its popular weight-loss drug, Mounjaro, in Hong Kong by…

(Reuters) -Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this…

(Reuters) -The U.S. Food and Drug Administration on Friday warned patients and doctors about dosing errors linked to compounded versions…